Recent advances of epilepsy associated with neurofibromatosis type 1
Background and aimNeurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome caused by pathogenic variants in the NF1 gene. It exhibits highly variable and unpredictable clinical manifestations involving multiple organ systems, with café-au-lait macules and multiple neurof...
Saved in:
| Main Authors: | Ying Ren, Wandong Hu, Song Su, Qi Zhang, Wenchao Zhang, Hongwei Zhang, Guangyu Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1640309/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)
by: R. N. Mustafin, et al.
Published: (2021-05-01) -
A COMPREHENSIVE APPROACH TO THE STUDY OF PECULIAR PROPERTIES OF NEUROFIBROMATOSIS TYPE 1
by: R. N. Mustafin, et al.
Published: (2017-01-01) -
The role of epigenetic factors in the pathogenesis of neurofibromatosis type 1
by: R. N. Mustafin, et al.
Published: (2017-10-01) -
Prospects for the use of statins in the treatment of neurofibromatosis type 1
by: R. N. Mustafin
Published: (2022-10-01) -
From genes to therapy: navigating the complex landscape of neurofibromatosis management in Canada through advanced diagnostic, targeted therapies, and holistic care
by: Victor Shu Cheng Zhao
Published: (2025-08-01)